Nanoco Group Plc (LON:NANO) CEO Michael Edelman talks to DirectorsTalk about the recently release half year results. Michael talks us through the highlights, updates us on its partnership with a US listed company for the scale up and mass production of novel nano-particles, talks about the display market and when to expect first products in the market, progress made in horticultural lighting, medical devices and life sciences, funding and the outlook for the rest of the year.
Nanoco Group Plc harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco’s proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar. It has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan. The company was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.
